Bowen Zhang

Bowen Zhang

Auto-generated profile, based on publicly available information

Bowen Zhang

Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering, College of Life Sciences Beijing Normal University Beijing 100875 China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Cell
Verified
Journal Article
Closed access
JSJonas Schulte-Schrepping
Jonas Schulte-Schrepping
NRNico Reusch
Nico Reusch
DPDaniela Paclik
Daniela Paclik
KBKevin Baßler
Kevin Baßler
SSStephan Schlickeiser
Stephan Schlickeiser
JZJohn Ziebuhr
John Ziebuhr

25 October 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
PDPriya A Debisarun
Priya A Debisarun
KGKatharina Gössling
Katharina Gössling
OBOzlem Bulut
Ozlem Bulut
GKGizem Kilic
Gizem Kilic
MZMartijn Zoodsma
Martijn Zoodsma
MNMihai G. Netea
Mihai G. Netea
Non-specific protective effects of certain vaccines have been reported, and long-term boosting of innate immunity, termedtrained immunity, has been proposed as one of the mechanisms mediating these effects. Several epidemiological studies suggested cross-protection between influenza vaccination and COVID-19. In a large academic Dutch hospital, we found that SARS-CoV-2 infection was less common among employees who had received a previous influenza vaccination: relative risk reductions of 37% and 49% were observed following influenza vaccination during the first and second COVID-19 waves, respectively. The quadrivalent inactivated influenza vaccine induced a trained immunity program that boosted innate immune responses against various viral stimuli and fine-tuned the anti-SARS-CoV-2 response, which may result in better protection against COVID-19. Influenza vaccination led to transcriptional reprogramming of monocytes and reduced systemic inflammation. These epidemiological and immunological data argue for potential benefits of influenza vaccination against COVID-19, and future randomized trials are warranted to test this possibility.

1 April 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
BZBowen Zhang
Bowen Zhang
SMSimone J.C.F.M Moorlag
Simone J.C.F.M Moorlag
JDJorge Dominguez-Andres
Jorge Dominguez-Andres
ÖBÖzlem Bulut
Özlem Bulut
GKGizem Kilic
Gizem Kilic
YLYang Li
Yang Li
Trained immunity refers to the long-lasting memory traits of innate immunity. Recent studies have shown that trained immunity is orchestrated by sustained changes in epigenetic marks and metabolic pathways, leading to an altered transcriptional response to a second challenge. However, the potential heterogeneity of trained-immunity induction in innate immune cells has not been explored. In this study, we demonstrate cellular transcriptional programs in response to 4 different inducers of trained immunity in monocyte populations at single-cell resolution. Specifically, we identified 3 monocyte subpopulations upon the induction of trained immunity, and replicated these findings in an in vivo study. In addition, we found gene signatures consistent with these functional programs in patients with ulcerative colitis, sepsis, and COVID-19, suggesting the impact of trained-immunity programs in immune-mediated diseases.

2 April 2021 in Science Immunology
Verified
Journal Article
Closed access
PDF file
LTLikai Tan
Likai Tan
AFAlina Suzann Fichtner
Alina Suzann Fichtner
EBElena Bruni
Elena Bruni
IOIvan Odak
Ivan Odak
ISInga Sandrock
Inga Sandrock
IPImmo Prinz
Immo Prinz
Innate-like human type 3 effector γδ T cells with canonical Vγ9Vδ2 + TCR develop in the earliest fetal thymus and persist into adulthood.

10 March 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MLMandy M. T. van Leent
Mandy M. T. van Leent
TBThijs J. Beldman
Thijs J. Beldman
YTYohana C. Toner
Yohana C. Toner
MLMarnix A. Lameijer
Marnix A. Lameijer
NRNils Rother
Nils Rother
RDRaphaël Duivenvoorden
Raphaël Duivenvoorden
Macrophages play a central role in the pathogenesis of atherosclerosis. The inflammatory properties of these cells are dictated by their metabolism, of which the mechanistic target of rapamycin (mTOR) signaling pathway is a key regulator. Using myeloid cell–specific nanobiologics in apolipoprotein E–deficient (Apoe−/−) mice, we found that targeting the mTOR and ribosomal protein S6 kinase-1 (S6K1) signaling pathways rapidly diminished plaque macrophages’ inflammatory activity. By investigating transcriptome modifications, we identified Psap, a gene encoding the lysosomal protein prosaposin, as closely related with mTOR signaling. Subsequent in vitro experiments revealed that Psap inhibition suppressed both glycolysis and oxidative phosphorylation. Transplantation of Psap−/− bone marrow to low-density lipoprotein receptor knockout (Ldlr−/−) mice led to a reduction in atherosclerosis development and plaque inflammation. Last, we confirmed the relationship between PSAP expression and inflammation in human carotid atherosclerotic plaques. Our findings provide mechanistic insights into the development of atherosclerosis and identify prosaposin as a potential therapeutic target.

2 December 2022 in Cell Genomics
Verified
Journal Article
Open access
BZBowen Zhang
Bowen Zhang
ZZZhenhua Zhang
Zhenhua Zhang
VKValerie A.C.M. Koeken
Valerie A.C.M. Koeken
SKSaumya Kumar
Saumya Kumar
MAMichelle Aillaud
Michelle Aillaud
YLYang Li
Yang Li
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes severe COVID-19 in some patients and mild COVID-19 in others. Dysfunctional innate immune responses have been identified to contribute to COVID-19 severity, but the key regulators are still unknown. Here, we present an integrative single-cell multi-omics analysis of peripheral blood mononuclear cells from hospitalized and convalescent COVID-19 patients. In classical monocytes, we identified genes that were potentially regulated by differential chromatin accessibility. Then, sub-clustering and motif-enrichment analyses revealed disease condition-specific regulation by transcription factors and their targets, including an interaction between C/EBPs and a long-noncoding RNA LUCAT1, which we validated through loss-of-function experiments. Finally, we investigated genetic risk variants that exhibit allele-specific open chromatin (ASoC) in COVID-19 patients and identified a SNP rs6800484-C, which is associated with lower expression of CCR2 and may contribute to higher viral loads and higher risk of COVID-19 hospitalization. Altogether, our study highlights the diverse genetic and epigenetic regulators that contribute to COVID-19.